Systemic Lupus Erythematosus | CHOP Research Institute
 

Systemic Lupus Erythematosus

VOCAL Trial

This is a study to measure the effectiveness of the medication voclosporin compared to placebo in adolescent patients with active lupus nephritis.

The CARRA Registry

The CARRA Registry

This is an observational registry of children and young adults with pediatric-onset rheumatic conditions such as juvenile idiopathic arthritis (JIA) and Systemic Lupus Erythematosus (SLE) and SLE-like conditions.

Sullivan Laboratory

Sullivan Lab

The Sullivan Lab has a broad interest in immune dysfunction. This can underlie susceptibility to infections and autoimmunity and inflammation. The investigators in the lab use cutting-edge approaches to investigate cause in individual patients and to look at population-wide causes of disease.

3-D Genome Mapping Uncovers Possible Treatment Targets in Lupus

Published on
Jul 13, 2020
in Cornerstone Blog
Nature Communications
Using a novel 3-D mapping of the genome of a particular cell type, researchers at CHOP identified new possible treatment targets in lupus.
Kathleen E. Sullivan, MD, PhD
Photo of Kathleen E. Sullivan

Dr. Sullivan's research focuses on new and rare immunodeficiencies. She has a long-standing interest in one of the most common of the primary immunodeficiencies – chromosome 22q11.2 deletion syndrome. She also investigates common variable immunodeficiency, as well as the genetics and epigenetics of systemic lupus erythematosus.

E-mail:
sullivank [at] chop.edu

Mind Meets Body in New Lupus Research: Q&A With Andrea Knight, Rheumatology Physician

Published on
Oct 11, 2017
in Cornerstone Blog
Andrea Knight, MD
As the recipient of a Novel Research Grant from the Lupus Research Alliance, Andrea Knight, MD, a physician in the division of Rheumatology, is working to better understand why children with systemic lupus erythematosus (SLE) experience mental health problems.